Vimarsana
Biggest News Aggregation in the World

Page 2 - Survival Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Survival Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Survival Data Today - Breaking & Trending Today

Portage Biotech Highlights Safety and Survival Data from Intensity Therapeutics' IT-01 Study of INT230-6 (PORT-1) at ASCO 2021 Annual Meeting - Vimarsana News

Portage Biotech Highlights Safety and Survival Data from Intensity Therapeutics' IT-01 Study of INT230-6 (PORT-1) at ASCO 2021 Annual Meeting

- Data from the IT-01 trial demonstrate the safety of INT230-6 (PORT-1) as both a monotherapy and in combination with checkpoint inhibitors in solid tumors - Survival data looks favorable compared to similar historical populations, balanced for prognostic factorsWestport, Connecticut--(Newsfile Corp. - June 2, 2021) - Portage Biotech Inc., (NASDAQ: PRTG) ("Portage" or the "Company") a ...

Source: yahoo.com
Continued survival benefit in Targovax's ONCOS-102 trial in mesothelioma at the 21-month follow-up - Vimarsana News

Continued survival benefit in Targovax's ONCOS-102 trial in mesothelioma at the 21-month follow-up

Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, today announces 21-month follow-up data from the randomized phase I/II trial of ONCOS-102 in combination with standard of care chemotherapy in malignant pleural mesothelioma (MPM).

Source: yahoo.com